8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease - Wikidata - thesis-toulmin - TriplyDB

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

http://www.wikidata.org/entity/Q24606651

about

Temporal analysis of neural differentiation using quantitative proteomics Shotgun proteomics in neuroscience Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approach Mass spectrometry for the detection of potential psychiatric biomarkers Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Proteomic discovery of host kinase signaling in bacterial infections Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease Relative, label-free protein quantitation: Spectral counting error statistics from nine replicate MudPIT samples Altered serine/threonine kinase activity in schizophrenia Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the inner ear Preprocessing significantly improves the peptide/protein identification sensitivity of high-resolution isobarically labeled tandem mass spectrometry data Proteomics in the study of hippocampal plasticity.Automated neutral loss and data dependent energy resolved "pseudo MS3" for the targeted identification, characterization and quantitative analysis of methionine- containing peptides.Auditory proteomics: methods, accomplishments and challenges.Differential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene.Quantitative proteomics by metabolic labeling of model organisms.Strategies for quantitation of phosphoproteomic data.Stable-isotope dilution LC–MS for quantitative biomarker analysis.Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.Classification of subcellular location by comparative proteomic analysis of native and density-shifted lysosomes Aliphatic dipeptide tags for multi-2-plex protein quantification.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Susceptibility to COPD: differential proteomic profiling after acute smoking Bayesian Analysis of iTRAQ Data with Nonrandom Missingness: Identification of Differentially Expressed Proteins.Proteomic and phosphoproteomic comparison of human ES and iPS cells.Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry.Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers.COMPASS: a suite of pre- and post-search proteomics software tools for OMSSA Isobaric labeling-based relative quantification in shotgun proteomics.Identification of thioredoxin target protein networks in cardiac tissues of a transgenic mouse.Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.Analyzing the cryptome: uncovering secret sequences.mzResults: an interactive viewer for interrogation and distribution of proteomics results.Quantitative strategies to fuel the merger of discovery and hypothesis-driven shotgun proteomics.Liquid chromatography-mass spectrometry-based quantitative proteomics.Multi-functional MBIT for peptide tandem mass spectrometry.Systems biology in immunology: a computational modeling perspective.

P2860

Q24648790-471D0355-EF27-4A83-B00E-04DF7E5273C3 Q24652437-76943FEE-6F54-4A43-B1D1-FC3567E4C2BC Q26830132-ED2F8CEF-82CB-4689-BED1-C21D4AD793BA Q26852637-BBA1889D-A953-4082-A87A-F6146C262D21 Q27024518-6A38AA80-9D47-42C2-8DA5-419C077C88D6 Q28079325-3F939F57-52BD-4DC2-8361-50E8432606A7 Q28476732-D5BD678E-E46A-4E85-A83A-AC94DA7096D7 Q28547212-F01A739D-8644-4649-938A-B91DA455C8A7 Q28743561-F766E156-6359-421A-A1CB-B5F8D02B5646 Q29037737-71DD9CEE-E0F1-4B84-9262-33B1611E77F3 Q30409979-DCF8322B-C4A8-47CC-86F3-0BBA3C0E1CC3 Q30473986-BC93E622-BB32-4AD7-9C84-04E57302157F Q30872546-ED2E5E23-1813-47DC-BEE3-D2FD0D2D8B3E Q33340655-12F291A6-64BA-42FD-9EEB-BE90C0A11E7A Q33364696-45C550B1-7F67-45B8-B8D1-86E89657313D Q33412935-9217F69D-8073-4BB9-8862-05A38FFA4B61 Q33530040-3505AA86-6D7F-404E-BD6C-D2AD92F6B8D2 Q33597953-8556B2C6-C877-4673-B6A6-7B47E10CFFF3 Q33600052-998A46F6-0FE9-4C0B-AA68-B061DC2F8540 Q33747062-F73450EF-E670-4D03-A8D2-8FEF05002566 Q33766323-D6DACD74-4118-4C16-8F4F-65481BE5FBF7 Q33798939-BEFD41E3-4259-47C1-8AB8-08F1737E4BB7 Q33835900-75F30E89-8397-451F-BDD0-434BC2878262 Q33891197-9F98E2F0-7D64-4F67-ABB8-6530CF4BD801 Q33921450-478B797C-F32F-4163-BD88-464752067078 Q34021823-E09EDCED-7175-497F-9DFB-CC11D6C5D243 Q34028873-5EDBAD9E-EE84-4D3F-BEDC-1CA45B4E8FA9 Q34065288-06651731-510D-4983-B3BC-CED8C4A740C0 Q34420715-25F19467-B223-4504-827F-315469169292 Q34557152-BEE49444-F91A-41A9-BF04-14A0D0966DDE Q34629832-864E85AF-6BBE-45A0-8791-B982D7DDB525 Q34669427-5F405AAB-768D-4304-B82F-0BBC1A30CC4B Q34680307-9E909E30-2269-4152-A543-094A3762E13E Q34735454-2A26BEE6-13E5-4730-9225-0449E5F6897F Q34901101-E70912A6-61EB-47D8-BFCE-ADF713246836 Q34994331-42F902BE-73C1-4873-A673-15445DDE4A7E Q35017506-E1F652CD-7B3E-4041-BA41-8AA68388CFC1 Q35111036-CA4F6E5F-7509-41F8-8F89-F487B04B6CE2 Q35175607-1A1E555D-492F-4B35-8FD4-F8543FDCE778 Q35189593-CE242DD0-75CD-4966-886C-B3D436E67443

P2860

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

http://www.wikidata.org/entity/Q24606651

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

8-plex quantitation of changes ...... atment for Alzheimer's disease

@ast

8-plex quantitation of changes ...... atment for Alzheimer's disease

@en

8-plex quantitation of changes ...... atment for Alzheimer's disease

@nl

type

label

8-plex quantitation of changes ...... atment for Alzheimer's disease

@ast

8-plex quantitation of changes ...... atment for Alzheimer's disease

@en

8-plex quantitation of changes ...... atment for Alzheimer's disease

@nl

prefLabel

8-plex quantitation of changes ...... atment for Alzheimer's disease

@ast

8-plex quantitation of changes ...... atment for Alzheimer's disease

@en

8-plex quantitation of changes ...... atment for Alzheimer's disease

@nl

P1433

Q24606651-33641F73-C2DC-4360-B3E2-B92566A85FD6

P1476

Q24606651-058639CB-4301-4973-850C-FEF3F31B1235

P2093

Q24606651-402F3D1E-9E00-4192-8C49-259B3CCD408F

Q24606651-683385E1-568C-42F1-90D5-A00467E96B4A

Q24606651-9599AA21-055B-4C75-8019-873B8A62E1C0

Q24606651-A28D0107-D552-4619-9560-C5C3ABCF4B65

Q24606651-C92946CE-E98E-45E3-8810-4A30BB66A25F

Q24606651-E9D265C0-D798-41D6-BBC7-AF8610248E10

Q24606651-EDB4E2B0-E8F9-4229-B540-7D78462E5715

Q24606651-FE71ACE1-B956-49CE-9C18-10D0BC2391F8

P2860

Q24606651-1DCB0A39-D09B-4FC9-9858-E93B8D98E3CB

Q24606651-2457A5E4-3B4A-4260-89C1-E87AA1869539

Q24606651-2582C41A-9E68-4F9C-B35D-7467F44F8A09

Q24606651-30966823-5E1F-4740-B77D-83177FDE5B31

Q24606651-34DF3AEF-4B38-4FCB-BCAE-2E1308956600

Q24606651-40889166-B257-4F60-89E3-82D0C5E5E1D0

Q24606651-58D30131-2EEC-481B-9273-AD3175EA9F0D

Q24606651-A2D5B548-973A-4D11-B7C1-C1E7EC98C648

Q24606651-A3063FE6-35E9-4349-B4E0-D4761F2A9543

Q24606651-A794B819-C7C5-4912-97FF-A69395F171BF

P304

Q24606651-87D233A9-E6D9-4347-AA04-AEA0CA895036

P31

Q24606651-F9C1A898-01DB-4C35-8523-7789DD63207B

P3181

Q24606651-0CB3ED46-2C2A-4817-AC34-A3D266E74456

P356

Q24606651-C15D73E3-5E81-43EA-A31D-D87BF5F0B501

P407

Q24606651-D2786634-8961-46FC-A576-6BEE571EE8BF

P433

Q24606651-6356E218-CB05-43D2-8D57-4F44533E09E4

P478

Q24606651-6CECB31E-9C1A-4EF7-AD8B-20B8BAD21A4D

P50

Q24606651-DC8B29FA-6CFD-4319-BCE0-8B0CF6906A52

P577

Q24606651-87855C91-45EE-46B7-941B-6A4BC5EFA0EE

P698

Q24606651-59BFFC2A-722B-4887-BF45-5E4B0F9AD11D

P921

Q24606651-14325756-6FCB-4346-B45E-0CD9FF71A6D4

Q24606651-F2666954-8941-47AF-9097-6D5BEFDB3376

P932

Q24606651-03C67E66-4E6A-41CD-A036-8271DCFE9DBA

P3181

P356

P1433

P1476

8-plex quantitation of changes ...... atment for Alzheimer's disease

@en

P2093

Brian Williamson

http://www.w3.org/2001/XMLSchema#string

Kelvin H Lee

http://www.w3.org/2001/XMLSchema#string

Leila Choe

http://www.w3.org/2001/XMLSchema#string

Mark D'Ascenzo

http://www.w3.org/2001/XMLSchema#string

Norman R Relkin

http://www.w3.org/2001/XMLSchema#string

Patrick Pribil

http://www.w3.org/2001/XMLSchema#string

Philip Ross

http://www.w3.org/2001/XMLSchema#string

Steven Guertin

http://www.w3.org/2001/XMLSchema#string

P2860

Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Proteomics: a technology-driven and technology-limited discovery science.

Interpretation of shotgun proteomic data: the protein inference problem.

Quantitative analysis of protein expression using amine-specific isobaric tags in Escherichia coli cells expressing rhsA elements.

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.

Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology.

Shotgun proteomics: integrating technologies to answer biological questions.

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.

P304

3651-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2433413

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/PMIC.200700316

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17880003

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

3594777

http://www.w3.org/2001/XMLSchema#string